Myocardial infarction: Difference between revisions
imported>Robert Badgett |
imported>Robert Badgett |
||
| Line 24: | Line 24: | ||
====Invasive treatment==== | ====Invasive treatment==== | ||
===Non ST-segment elevation myocardial infarction (NSTEMI)=== | |||
Among patients with unstable angina or NSTEMI, patients with ST-segment changes (e.g. depression or a transient elevation), a TIMI risk score of 3 or more, elevated myocardial enzymes, and elderly patients may be most likely to benefit from invasive management according to the TACTICS [[randomized controlled trial]].<ref name="pmid11419424">{{cite journal |author=Cannon CP, Weintraub WS, Demopoulos LA, ''et al'' |title=Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban |journal=N. Engl. J. Med. |volume=344 |issue=25 |pages=1879-87 |year=2001 |pmid=11419424 |doi= |url=http://content.nejm.org/cgi/pmidlookup?view=short&pmid=11419424&promo=ONFLNS19 |issn=}}</ref><ref name="pmid15289215">{{cite journal |author=Bach RG, Cannon CP, Weintraub WS, ''et al'' |title=The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes |journal=Ann. Intern. Med. |volume=141 |issue=3 |pages=186-95 |year=2004 |pmid=15289215 |doi=}}</ref> | |||
===ST-segment elevation myocardial infarction (STEMI)=== | |||
Primary angioplasty is better than thrombolysis if the angioplasty can be performed with less than a 90 minute delay.<ref name="pmid17277350">{{cite journal |author=Asseburg C, Vergel YB, Palmer S, ''et al'' |title=Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis |journal=Heart |volume=93 |issue=10 |pages=1244–50 |year=2007 |pmid=17277350 |doi=10.1136/hrt.2006.093336}}</ref> | Primary angioplasty is better than thrombolysis if the angioplasty can be performed with less than a 90 minute delay.<ref name="pmid17277350">{{cite journal |author=Asseburg C, Vergel YB, Palmer S, ''et al'' |title=Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis |journal=Heart |volume=93 |issue=10 |pages=1244–50 |year=2007 |pmid=17277350 |doi=10.1136/hrt.2006.093336}}</ref> | ||
Revision as of 09:50, 1 April 2008
A myocardial infarction, or "heart attack", is defined as "gross necrosis of the myocardium, as a result of interruption of the blood supply to the area".[1] The coronary arteries are the blood vessels that supply the heart muscle.
Pathophysiology
Most myocardial infarctions are due to atherosclerosis.
Stunned myocardium
The area of damage in the heart that results from decreased blood supply is usually larger than the infarct.[2] In other words, when the blood supply becomes inadequate (Ischemia) and the hard-working cardiac muscle cells are deprived of oxygen and nutrients, at least some of the affected muscle cells may be impaired by this loss rather than killed. By definition, if an infarct has occurred, at least some of these muscle cell have died- but many others may have become swollen or injured and yet, with restoration of the blood supply, are able to eventually recover.
Classification
Non-ST segment elevation myocardial infarction (NSTEMI)
ST segment elevation myocardial infarction (STEMI)
Treatment
NSTEMI
Clinical practice guidelines address the treatment of NSTEMI.[3] Primary angioplasty is "indicated for patients with UA/NSTEMI who have no serious comorbidity and who have coronary lesions amenable to PCI and any of the high-risk features."[3]
STEMI
Medications
Glucose-insulin-potassium infusion
Glucose-insulin-potassium (GIK) infusion does not benefit patients according to a randomized controlled trial.[4] However, there are concerns about the design of the trial.[5]
Invasive treatment
Non ST-segment elevation myocardial infarction (NSTEMI)
Among patients with unstable angina or NSTEMI, patients with ST-segment changes (e.g. depression or a transient elevation), a TIMI risk score of 3 or more, elevated myocardial enzymes, and elderly patients may be most likely to benefit from invasive management according to the TACTICS randomized controlled trial.[6][7]
ST-segment elevation myocardial infarction (STEMI)
Primary angioplasty is better than thrombolysis if the angioplasty can be performed with less than a 90 minute delay.[8]
Complications
Dysrhythmia
Pump Failure
References
- ↑ National Library of Medicine. Myocardial infarction. Retrieved on 2007-10-28.
- ↑ Solomon SD, Glynn RJ, Greaves S, et al (2001). "Recovery of ventricular function after myocardial infarction in the reperfusion era: the healing and early afterload reducing therapy study". Ann. Intern. Med. 134 (6): 451–8. PMID 11255520. [e]
- ↑ 3.0 3.1 Anderson JL, Adams CD, Antman EM, et al (2007). "ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine". J. Am. Coll. Cardiol. 50 (7): e1–e157. DOI:10.1016/j.jacc.2007.02.013. PMID 17692738. Research Blogging.
- ↑ Mehta SR, Yusuf S, Díaz R, et al (2005). "Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial". JAMA 293 (4): 437–46. DOI:10.1001/jama.293.4.437. PMID 15671428. Research Blogging.
- ↑ Cobb LA, Killip T, Lambrew CT, et al (2005). "Glucose-insulin-potassium infusion and mortality in the CREATE-ECLA trial". JAMA 293 (21): 2597; author reply 2598. DOI:10.1001/jama.293.21.2597-a. PMID 15928278. Research Blogging.
- ↑ Cannon CP, Weintraub WS, Demopoulos LA, et al (2001). "Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban". N. Engl. J. Med. 344 (25): 1879-87. PMID 11419424. [e]
- ↑ Bach RG, Cannon CP, Weintraub WS, et al (2004). "The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes". Ann. Intern. Med. 141 (3): 186-95. PMID 15289215. [e]
- ↑ Asseburg C, Vergel YB, Palmer S, et al (2007). "Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis". Heart 93 (10): 1244–50. DOI:10.1136/hrt.2006.093336. PMID 17277350. Research Blogging.